aod9604 lipolytic peptide AOD-9604 10mg AOD 9604 Peptide: The Complete

Notably, NAM serves as the substrate for NAD + synthesis in the salvage pathway (Pissios, 2017)

Adding 2ml creates 1mg/ml (1000mcg/ml)

Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials

Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company